Microbiome in pancreatic cancer – What is new in 2024?
Microbiota in Health and Disease · 2024-10 · 6
DOI: 10.26355/mhd_202410_1100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiota in Health and Disease, 2024-10. Verfasst von E. Hohmann und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Despite great efforts to improve understanding and treatment of pancreatic cancer, mainly pancreatic ductal adenocarcinoma (PDAC), the outcome of this malignant disease today is still very poor. With the introduction of modern sequencing methods and improvements in computational possibilities, microbiome research is an improving and promising field with a link to many possible diseases. In this article, the results of how the microbiome and PDAC influence each other are reviewed, and future directions are discussed.
Schlagwörter
Zitieren
APA
Hohmann, E., Ammer-Herrmenau, C., Schulz, C., & Sirtl, S. (2024). Microbiome in pancreatic cancer – What is new in 2024?. Microbiota in Health and Disease, 6. https://doi.org/10.26355/mhd_202410_1100
Vancouver
Hohmann E, Ammer-Herrmenau C, Schulz C, Sirtl S. Microbiome in pancreatic cancer – What is new in 2024?. Microbiota in Health and Disease. 2024;6. doi:10.26355/mhd_202410_1100
BibTeX
@article{Hohmann2024,
author = {Hohmann, E. and Ammer-Herrmenau, C. and Schulz, C. and Sirtl, S.},
title = {Microbiome in pancreatic cancer – What is new in 2024?},
journal = {Microbiota in Health and Disease},
year = {2024},
volume = {6},
doi = {10.26355/mhd_202410_1100}
}
EUVIMED